MARSHALL WACE, LLP - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 113 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,655,988
+8008.7%
1,048,646
+5926.7%
0.01%
Q2 2023$57,420
-83.3%
17,400
-85.6%
0.00%
-100.0%
Q1 2023$344,850
+205.1%
121,000
+679.3%
0.00%
Q4 2022$113,029
-30.2%
15,526
-22.8%
0.00%
Q3 2022$162,000
-32.2%
20,115
+48.9%
0.00%
Q4 2021$239,000
-94.4%
13,513
-91.1%
0.00%
-100.0%
Q3 2021$4,278,000151,6890.02%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders